GlassScriptPhysician profile
Ivan Olesh
NPI 1215565668
$2,291.87
in general payments reported to CMS, 2019-2025
10 companies · $477 in 2025
The $477 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.33 · 2022: $364 · 2023: $386 · 2024: $972 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,835.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $854.93 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $516.19 | 2021-2025 | Inspiris Resilia Aortic Valve, Konect Resilia, Hemosphere |
| Atricure, INC. | $441.63 | 2022-2023 | |
| Medical Device Business Services, INC. | $162.78 | 2024 | Stratafix, Vistaseal, Evarrest |
| Medtronic, INC. | $124.12 | 2022 | |
| Getinge USA Sales, LLC | $72.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $38.52 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.16 | 2025 | Lifevest |
| Amgen INC. | $24.52 | 2024 | Vectibix, Nplate |
| Terumo Cardiovascular Systems Corporation | $18.04 | 2024 | Capiox Fx Advance Hollow Fiber Oxygenator W Integrated Af W Hardshell Res. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Olesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.